Surgical removal of the tumor is considered the basis for curing gastric cancer. However, 40% of patients who have undergone surgery suffer a relapse within two years. A research team led by MedUni Vienna has now investigated a prognostic marker that can be used to identify patients with a high risk of tumor recurrence. The study’s results, recently published in the journal Scientific Reports, can therefore improve personalized treatment for stomach cancer and increase the chances of survival for those affected.
Medical Xpress – latest medical and health news stories
Discover more from Nurse Unity Chats
Subscribe to get the latest posts sent to your email.
